Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

China · Delayed Price · Currency is CNY

17.25

-0.15 (-0.86%)

Oct 14, 2026, 11:29 AM CST

Market Cap	2.89B -38.2%
Revenue (ttm)	1.23B +2.6%
Net Income	9.96M -93.2%
EPS	0.06 -93.5%
Shares Out	167.44M
PE Ratio	292.45
Forward PE	11.37
Dividend	0.25 (1.45%)
Ex-Dividend Date	Jun 3, 2026

Volume	1,208,736
Open	17.40
Previous Close	17.40
Day's Range	17.00 - 17.42
52-Week Range	14.61 - 29.81
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2008

Employees 601

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688687

Full Company Profile

Financial Performance

In 2025, SHA:688687's revenue was 1.32 billion, an increase of 7.35% compared to the previous year's 1.23 billion. Earnings were 30.60 million, a decrease of -78.51%.

Financial Statements